Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition
December 5, 2025
Qualigen Therapeutics Reports Positive QN-247 Readout in Triple Negative Breast Cancer in Vivo Model
August 1, 2022
Related Post
-
-
Protara Announces Pricing of $75 Million Public Offering
December 4, 2025
-
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
December 1, 2025
-
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
November 26, 2025